Roberto Latini

38.6k total citations · 9 hit papers
424 papers, 23.1k citations indexed

About

Roberto Latini is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Roberto Latini has authored 424 papers receiving a total of 23.1k indexed citations (citations by other indexed papers that have themselves been cited), including 240 papers in Cardiology and Cardiovascular Medicine, 59 papers in Surgery and 54 papers in Molecular Biology. Recurrent topics in Roberto Latini's work include Heart Failure Treatment and Management (102 papers), Cardiovascular Function and Risk Factors (79 papers) and Cardiac electrophysiology and arrhythmias (62 papers). Roberto Latini is often cited by papers focused on Heart Failure Treatment and Management (102 papers), Cardiovascular Function and Risk Factors (79 papers) and Cardiac electrophysiology and arrhythmias (62 papers). Roberto Latini collaborates with scholars based in Italy, United States and United Kingdom. Roberto Latini's co-authors include Aldo P. Maggioni, Gianni Tognoni, Serge Masson, Jay N. Cohn, Inder S. Anand, Luciano Gattinoni, Antonio Pesenti, Simona Barlera, Roberto Fumagalli and Luca Brazzi and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Roberto Latini

416 papers receiving 22.3k citations

Hit Papers

A Trial of Goal-Oriented ... 1995 2026 2005 2015 1995 2001 2014 1999 2003 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Trial of Goal-Oriented Hemodynamic Therapy in Critically Ill Patients
    1995 912 citations Roberto Latini, Gianni Tognoni et al. profile →
  2. Effect of Prone Positioning on the Survival of Patients with Acute Respiratory Failure
    2001 749 citations Gianni Tognoni, Roberto Latini et al. profile →
  3. Albumin Replacement in Patients with Severe Sepsis or Septic Shock
    2014 727 citations Serge Masson, Roberto Latini et al. profile →
  4. Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure
    1999 662 citations Roberto Latini, Aldo P. Maggioni et al. Circulation profile →
  5. Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
    2003 661 citations Inder S. Anand, YannTong Chiang et al. Circulation profile →
  6. Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure
    2007 549 citations Roberto Latini, Serge Masson et al. Circulation profile →
  7. Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
    2004 527 citations Michael Brines, Giovanni Grasso et al. Proceedings of the National Academy of Sciences profile →
  8. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
    2003 501 citations Roberto Latini, Pietro Ghezzi et al. Proceedings of the National Academy of Sciences profile →
  9. Understanding the Complex of Suicide in Depression: from Research to Clinics
    2020 260 citations Roberto Latini et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Roberto Latini 11.2k 3.6k 3.5k 3.0k 3.0k 424 23.1k
Peter A. McCullough 17.6k 1.6× 6.7k 1.9× 6.7k 1.9× 2.2k 0.7× 3.2k 1.1× 612 37.0k
Malte Kelm 9.3k 0.8× 4.2k 1.2× 2.4k 0.7× 3.8k 1.3× 2.0k 0.7× 829 25.0k
Alan S. Maisel 16.6k 1.5× 3.4k 1.0× 3.4k 1.0× 2.0k 0.7× 2.9k 1.0× 423 23.2k
Marco Metra 23.9k 2.1× 4.1k 1.2× 5.7k 1.6× 3.0k 1.0× 2.2k 0.7× 808 32.4k
James L. Januzzi 27.1k 2.4× 6.7k 1.9× 6.6k 1.9× 3.4k 1.1× 2.9k 1.0× 745 39.4k
Frank Ruschitzka 14.8k 1.3× 3.8k 1.1× 2.7k 0.8× 1.9k 0.6× 1.5k 0.5× 384 21.4k
Christopher M. O’Connor 33.2k 3.0× 6.5k 1.8× 6.0k 1.7× 2.2k 0.7× 2.8k 0.9× 655 41.5k
Adriaan A. Voors 28.3k 2.5× 5.6k 1.6× 7.2k 2.1× 5.1k 1.7× 3.1k 1.0× 688 41.4k
Eldrin F. Lewis 7.4k 0.7× 3.7k 1.0× 2.2k 0.6× 2.0k 0.7× 1.3k 0.4× 223 16.8k
Mihai Gheorghiade 18.7k 1.7× 3.9k 1.1× 6.0k 1.7× 3.5k 1.2× 1.7k 0.6× 411 26.1k

Countries citing papers authored by Roberto Latini

Since Specialization
Citations

This map shows the geographic impact of Roberto Latini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Latini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Latini more than expected).

Fields of papers citing papers by Roberto Latini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Latini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Latini. The network helps show where Roberto Latini may publish in the future.

Co-authorship network of co-authors of Roberto Latini

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Latini. A scholar is included among the top collaborators of Roberto Latini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Latini. Roberto Latini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shadman, Ramin, Jeanne E. Poole, Todd Dardas, et al.. (2024). Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50%. American Heart Journal. 275. 35–44.
2.
Magliocca, Aurora, Carlo Perego, F. Motta, et al.. (2023). Indoleamine 2,3-Dioxygenase Deletion to Modulate Kynurenine Pathway and to Prevent Brain Injury after Cardiac Arrest in Mice. Anesthesiology. 139(5). 628–645. 4 indexed citations
3.
Ferrannini, Giulia, Maria Laura Manca, Marco Magnoni, et al.. (2020). Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study. Diabetes Care. 43(4). 843–851. 44 indexed citations
4.
Aspromonte, Nadia, Michele Massimo Gulizia, Aldo Clerico, et al.. (2016). Documento di consenso ANMCO/ELAS/SIBioC: Raccomandazioni sull’impiego dei biomarcatori cardiaci nello scompenso cardiaco. Giornale italiano di cardiologia. 17(9). 615–656. 3 indexed citations
5.
Latini, Roberto, Lidia Staszewsky, & Filippo Ottani. (2015). Il ruolo dei mitocondri sul danno da riperfusione coronarica come potenziale target farmacologico: luci ed ombre. Giornale italiano di cardiologia. 16(10). 544–8. 1 indexed citations
6.
Ueland, Thor, Ståle H. Nymo, Roberto Latini, et al.. (2013). CCL21 is Associated with Fatal Outcomes in Chronic Heart Failure: Data from CORONA and GISSI-HF Trials. European Journal of Heart Failure. 15(7). 747–755. 15 indexed citations
7.
Aleksova, Aneta, Serge Masson, Aldo P. Maggioni, et al.. (2013). n -3 Polyunsaturated Fatty Acids and Atrial Fibrillation in Patients with Chronic Heart Failure: the GISSI-HF Trial. European Journal of Heart Failure. 15(11). 1289–1295. 32 indexed citations
8.
Mureddu, Gian Francesco, Luigi Tarantini, Nera Agabiti, et al.. (2013). Evaluation of Different Strategies for Identifying Asymptomatic Left Ventricular Dysfunction and Pre-Clinical (stage B) Heart Failure in the Elderly. Results from ‘PREDICTOR’, a Population Based-Study in Central Italy. European Journal of Heart Failure. 15(10). 1102–1112. 23 indexed citations
9.
Lesogor, Anastasia, Jay N. Cohn, Roberto Latini, et al.. (2013). Interaction Between Baseline and Early Worsening of Renal Function and Efficacy of Renin–Angiotensin–Aldosterone System Blockade in Patients with Heart Failure: Insights from the Val-HeFT Study. European Journal of Heart Failure. 15(11). 1236–1244. 45 indexed citations
10.
Mureddu, Gian Francesco, Nera Agabiti, Vittoria Rizzello, et al.. (2012). Prevalence of Preclinical and Clinical Heart Failure in the Elderly. A Population-Based Study in Central Italy. European Journal of Heart Failure. 14(7). 718–729. 78 indexed citations
11.
Latini, Roberto, Lars Gullestad, Serge Masson, et al.. (2012). Pentraxin-3 in Chronic Heart Failure: The CORONA and GISSI-HF Trials. European Journal of Heart Failure. 14(9). 992–999. 80 indexed citations
12.
Damman, Kevin, Serge Masson, Hans L. Hillege, et al.. (2011). Clinical outcome of renal tubular damage in chronic heart failure†. European Heart Journal. 32(21). 2705–2712. 171 indexed citations
13.
Masson, Serge, Inder S. Anand, Chiara Favero, et al.. (2011). Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart Failure. Circulation. 125(2). 280–288. 168 indexed citations
14.
Pitt, Bertram, Roberto Latini, Aldo P. Maggioni, et al.. (2011). Neurohumoral Effects of Aliskiren in Patients with Symptomatic Heart Failure Receiving a Mineralocorticoid Receptor Antagonist: The Aliskiren Observation of Heart Failure Treatment Study. European Journal of Heart Failure. 13(7). 755–764. 20 indexed citations
15.
Masson, Serge, Roberto Latini, Emanuele Carbonieri, et al.. (2010). The Predictive Value of Stable Precursor Fragments of Vasoactive Peptides in Patients with Chronic Heart Failure: Data from the GISSI-Heart Failure (GISSI-HF) Trial. European Journal of Heart Failure. 12(4). 338–347. 126 indexed citations
16.
Ghio, Stefano, Laura Scelsi, Roberto Latini, et al.. (2010). Effects of n -3 Polyunsaturated Fatty Acids and of Rosuvastatin on Left Ventricular Function in Chronic Heart Failure: A Substudy of GISSI-HF trial. European Journal of Heart Failure. 12(12). 1345–1353. 72 indexed citations
17.
McMurray, John J.V., Bertram Pitt, Roberto Latini, et al.. (2008). Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure. Circulation Heart Failure. 1(1). 17–24. 276 indexed citations
18.
19.
Wong, Maylene, Lidia Staszewsky, Elisa Carretta, et al.. (2005). Signs and Symptoms in Chronic Heart Failure: Relevance of Clinical Trial Results to Point of Care—Data from Val-HeFT. European Journal of Heart Failure. 8(5). 502–508. 9 indexed citations
20.
Brines, Michael, Giovanni Grasso, Fabio Fiordaliso, et al.. (2004). Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor. Proceedings of the National Academy of Sciences. 101(41). 14907–14912. 527 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter A. McCullough Breakdown of academic impact, for papers by Malte Kelm Breakdown of academic impact, for papers by Alan S. Maisel Breakdown of academic impact, for papers by Marco Metra Breakdown of academic impact, for papers by James L. Januzzi Breakdown of academic impact, for papers by Frank Ruschitzka Breakdown of academic impact, for papers by Christopher M. O’Connor Breakdown of academic impact, for papers by Adriaan A. Voors Breakdown of academic impact, for papers by Eldrin F. Lewis Breakdown of academic impact, for papers by Mihai Gheorghiade
Rankless by CCL
2026